{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:43:43Z","timestamp":1792237423428,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1124\/dmd.110.036392","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T02:21:26Z","timestamp":1287627686000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Generation of Human Chiral Metabolites of Simvastatin and Lovastatin by Bacterial CYP102A1 Mutants"],"prefix":"10.1016","volume":"39","author":[{"given":"Keon-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Ha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Ha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dooil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Deok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung-Chae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Gu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeho","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Ho","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.036392_bib1","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP Model","volume":"97","author":"Bayly","year":"1993","journal-title":"J Phys Chem"},{"key":"10.1124\/dmd.110.036392_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11095-006-9199-7","article-title":"Predicting the oxidative metabolism of statins: an application of the MetaSite algorithm","volume":"24","author":"Caron","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.110.036392_bib3","series-title":"AMBER 10","author":"Case","year":"2008"},{"key":"10.1124\/dmd.110.036392_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cbi.2007.09.007","article-title":"Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites","volume":"171","author":"Damsten","year":"2008","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.110.036392_bib5","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N \u00b7 log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"10.1124\/dmd.110.036392_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1358\/mf.2003.25.6.769652","article-title":"Clinical pharmacokinetics of statins","volume":"25","author":"Garc\u00eda","year":"2003","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1124\/dmd.110.036392_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.260371116","article-title":"Development of a large-scale continuous substrate feed process for the biotransformation of simvastatin by Nocardia sp","volume":"37","author":"Gbewonyo","year":"1991","journal-title":"Biotechnol Bioeng"},{"key":"10.1124\/dmd.110.036392_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcc.10379","article-title":"Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf","volume":"25","author":"Gohlke","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1124\/dmd.110.036392_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrd792","article-title":"Cytochrome P450 enzymes in the generation of commercial products","volume":"1","author":"Guengerich","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.110.036392_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/mi.3.4.194","article-title":"Cytochromes P450, drugs, and diseases","volume":"3","author":"Guengerich","year":"2003","journal-title":"Mol Interv"},{"key":"10.1124\/dmd.110.036392_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/tx900003k","article-title":"Introduction: Human metabolites in safety testing (MIST) issue","volume":"22","author":"Guengerich","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.036392_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jmb.2007.08.015","article-title":"Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency","volume":"373","author":"Huang","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1124\/dmd.110.036392_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:BREA.0000025406.31193.e8","article-title":"Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen","volume":"85","author":"Johnson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1124\/dmd.110.036392_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"key":"10.1124\/dmd.110.036392_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbpa.2008.01.029","article-title":"Heme-iron oxygenases: powerful industrial biocatalysts?","volume":"12","author":"Julsing","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/dmd.110.036392_bib16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/dmd.108.026484","article-title":"Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3","volume":"37","author":"Kim","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.pep.2007.10.010","article-title":"Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli","volume":"57","author":"Kim","year":"2008","journal-title":"Protein Expr Purif"},{"key":"10.1124\/dmd.110.036392_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcatb.2010.01.017","article-title":"Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3","volume":"63","author":"Kim","year":"2010","journal-title":"J Mol Catal B Enzym"},{"key":"10.1124\/dmd.110.036392_bib19","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.108.021220","article-title":"Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3","volume":"36","author":"Kim","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect Drug Discov Des"},{"key":"10.1124\/dmd.110.036392_bib21","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J Comput Chem"},{"key":"10.1124\/dmd.110.036392_bib22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/dmd.109.030759","article-title":"Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation","volume":"38","author":"Park","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/dmd.30.5.505","article-title":"Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization","volume":"30","author":"Prueksaritanont","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/mben.2000.0147","article-title":"Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites","volume":"2","author":"Rushmore","year":"2000","journal-title":"Metab Eng"},{"key":"10.1124\/dmd.110.036392_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1124\/dmd.110.036392_bib26","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1002\/chem.200900643","article-title":"A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds","volume":"15","author":"Sawayama","year":"2009","journal-title":"Chemistry"},{"key":"10.1124\/dmd.110.036392_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/prot.21697","article-title":"Structural rationalization of novel drug metabolizing mutants of cytochrome P450 BM3","volume":"71","author":"Stjernschantz","year":"2008","journal-title":"Proteins"},{"key":"10.1124\/dmd.110.036392_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1742-7843.2005.pto_134.x","article-title":"Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8","volume":"97","author":"Tornio","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.110.036392_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002280050094","article-title":"In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors","volume":"50","author":"Transon","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.110.036392_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/bi962359z","article-title":"Cooperativity in oxidations catalyzed by cytochrome P450 3A4","volume":"36","author":"Ueng","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.110.036392_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.tibtech.2006.05.002","article-title":"Cytochrome P450 monooxygenases: perspectives for synthetic application","volume":"24","author":"Urlacher","year":"2006","journal-title":"Trends Biotechnol"},{"key":"10.1124\/dmd.110.036392_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10295-004-0202-1","article-title":"Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli","volume":"32","author":"Vail","year":"2005","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1124\/dmd.110.036392_bib33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/00268977700102571","article-title":"Algorithms for macromolecular dynamics and constraint dynamics","volume":"34","author":"van Gunsteren","year":"1977","journal-title":"Mol Phys"},{"key":"10.1124\/dmd.110.036392_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/jm0609061","article-title":"Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis","volume":"50","author":"van Vugt-Lussenburg","year":"2007","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.110.036392_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-9556(25)07595-6","article-title":"Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug","volume":"18","author":"Vickers","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0090-9556(25)08543-5","article-title":"In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase","volume":"18","author":"Vickers","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0090-9556(25)07606-8","article-title":"Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse","volume":"18","author":"Vyas","year":"1990","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.036392_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1124\/dmd.110.036392_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tibtech.2007.05.003","article-title":"The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities","volume":"25","author":"Yun","year":"2007","journal-title":"Trends Biotechnol"},{"key":"10.1124\/dmd.110.036392_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/138920006776873472","article-title":"Functional expression of human cytochrome P450 enzymes in Escherichia coli","volume":"7","author":"Yun","year":"2006","journal-title":"Curr Drug Metab"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624224089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624224089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.036392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:59:02Z","timestamp":1739908742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624224089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0090955624224089"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.036392","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of Human Chiral Metabolites of Simvastatin and Lovastatin by Bacterial CYP102A1 Mutants","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.036392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}